Shopping Cart 0
Cart Subtotal
AED 0

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 27525

Details

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019

Summary

GlobalData's clinical trial report, Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

List of Tables

List of Figures

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Countries Contributing to Clinical Trials in Middle East and Africa

Top Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Diabetic Neuropathic Pain Therapeutics Clinical Trials

Prominent Drugs

Latest Clinical Trials News on Diabetic Neuropathic Pain

Mar 28, 2019: Aptinyx to present detailed results from phase 2 painful DPN study of NYX-2925 at American Pain Society Scientific Meeting

Mar 20, 2019: Syntrix announces first patient cohort dosed in Phase 2 study of desmetramadol in Diabetic Neuropathic Pain

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Disclaimer

Source


List Of Figure

List of Figures

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Region (%), 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018

Diabetic Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

GlobalData Methodology


List Of Table

List of Tables

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Region, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018

Diabetic Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Diabetic Neuropathic Pain Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Diabetic Neuropathic Pain. Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Companies

Eli Lilly and Co

Daiichi Sankyo Co Ltd

Teva Pharmaceutical Industries Ltd

Grunenthal GmbH

Johnson & Johnson

Pfizer Inc

Mundipharma International Ltd

Intas Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd

Alfred E. Tiefenbacher GmbH & Co KG

Company Profile

Company Profile Title

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019

Summary

GlobalData's clinical trial report, Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

List of Tables

List of Figures

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Countries Contributing to Clinical Trials in Middle East and Africa

Top Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Diabetic Neuropathic Pain Therapeutics Clinical Trials

Prominent Drugs

Latest Clinical Trials News on Diabetic Neuropathic Pain

Mar 28, 2019: Aptinyx to present detailed results from phase 2 painful DPN study of NYX-2925 at American Pain Society Scientific Meeting

Mar 20, 2019: Syntrix announces first patient cohort dosed in Phase 2 study of desmetramadol in Diabetic Neuropathic Pain

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Disclaimer

Source


List Of Figure

List of Figures

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Region (%), 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018

Diabetic Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

GlobalData Methodology


List Of Table

List of Tables

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Region, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*

Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2019*

Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018

Diabetic Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*

Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Diabetic Neuropathic Pain Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Diabetic Neuropathic Pain. Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Companies

Eli Lilly and Co

Daiichi Sankyo Co Ltd

Teva Pharmaceutical Industries Ltd

Grunenthal GmbH

Johnson & Johnson

Pfizer Inc

Mundipharma International Ltd

Intas Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd

Alfred E. Tiefenbacher GmbH & Co KG